VEGFA and renal carcinoma: Furthermore, in human OC and renal carcinoma cells, Res inhibits angiogenesis via the decreased expression of HIF-1α (hypoxia-inducible factor-1α) and vascular endothelial growth factor (VEGF) [25,26], which indicates its potential against angiogenesis-mediated metastases [27,28,29].